Filter
114
Filtered Results: 114
Text search:
Panel
on
Opportunistic
Infections
in
HIV-Infected
Adults
and
Adolescents
Featured
Recommendations
9
New Publications
33
Language
Document type
No document type
92
Guidelines
13
Studies & Reports
6
Manuals
1
Situation Updates
1
Infographics
1
Countries / Regions
India
16
Nepal
3
Zambia
3
South Africa
3
Namibia
3
Latin America and the Carribbean
3
USA
2
Ethiopia
2
Uganda
2
Tanzania
2
Cambodia
2
Malawi
2
Lesotho
2
Eastern Europe
2
Albania
2
Russia
2
Liberia
1
Pakistan
1
Afghanistan
1
Kenya
1
Thailand
1
Bangladesh
1
Mozambique
1
Ukraine
1
Myanmar / Burma
1
Sri Lanka
1
Western and Central Europe
1
Asia
1
Bhutan
1
Southern Africa
1
Global
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
41
Clinical Guidelines
23
Capacity Building
5
Women & Child Health
5
Public Health
2
Pharmacy & Technologies
1
Toolboxes
HIV
46
TB
11
Mental Health
2
NTDs
2
Refugee
1
COVID-19
1
Social Ethics
1
Caregiver
1
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis ... cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and reduce mortality. The purpose of the meeting was to
Review the current research and implementation data on the use of prophylactic antibiotics (specifically azithromycin/macrolides) as part of the AHD package of care; To review options for preventing SBIs that are in line with goals of reducing AMR; Present the current evidence on diagnostics for SBI; Discuss research gaps and implementation challenges.
This document updates recommendations for HIV testing by laboratories in the United States and offers approaches for reporting test results to pers...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America ... is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV
With this study, we estimated the burden of serious fungal infections for the general healthy population and for those at risk, including those infected...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations ... the preferred regimens based on a patient’s HCV genotype and clinical history, and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 2014
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age ... point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living with HIV who are being treated for tuberculosis.
New recommendations launched today outline key new actions that countries can take to improve the delivery of HIV testing, treatment and care services by providing greater options for differentiated approaches such as, supporting HIV treatment start in the community, ensuring that children are diagnosed and treated early, and that viral load treatment monitoring is more accessible, focused and triggers clinical action
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution ... prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
National Tuberculosis Programme and Senior Paediatricians
This guideline was first developed in 2007 but further updated in 2012 ... 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to TB in children and will help to achieve an internationally recommended standard of care at all levels of the health system in Myanmar.
This guideline was first developed in 2007 but further updated in 2012 ... 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to TB in children and will help to achieve an internationally recommended standard of care at all levels of the health system in Myanmar.
Zanoni BC, et al. BMJ Glob Health 2016;1:e000004. doi:10.1136/bmjgh-2015-000004
· Relevant interventions
· HIV country profiles
· Adolescents country profiles
National Tuberclosis and
Leprosy Programme (NTLP)
The curriculum, which complements the national pediatric ART training, was finalized in 2011 and was subsequently implemented nationally. The training curriculum includes a 15-module Trainer Manual,...
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national ... site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additional indicators for site-level, national and global reporting.
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals ... policy-makers. They are also important in improving access to controlled medicines for determining when those opioid medicines and when non-opioid medicines are preferred.
Based on a Delphi study, WHO planned the development of three treatment guidelines, covering chronic pain in children, chronic pain in adults and acute pain.
